Related Subjects:
|Drug Toxicity - Assessment
|Metabolic acidosis
|Aspirin or Salicylates toxicity
|Ethylene glycol toxicity
|Ethanol toxicity
|Methanol toxicity
|Ricin toxicity
|Carbon Tetrachloride Toxicity
|Renal Tubular Acidosis
|Lactic acidosis
|Iron Toxicity
|Tricyclic Antidepressant Toxicity
|Opiate Toxicity
|Carbon monoxide Toxicity
|Benzodiazepine Toxicity
|Paracetamol (Acetaminophen) toxicity
|Amphetamine toxicity
|Beta Blocker toxicity
|Calcium channel blockers toxicity
|Cannabis toxicity
|Cyanide toxicity
|Digoxin Toxicity
|Lithium Toxicity
|NSAIDS Toxicity
|Ecstasy toxicity
|Paraquat toxicity
|Quinine toxicity
|SSRI Toxicity
|Theophylline Toxicity
|LSD Toxicity
|Organophosphate (OP) Toxicity
|Toxin elimination by dialysis
|Drug Toxicity with Specific Antidotes
๐ About LSD
- D-Lysergic acid diethylamide (LSD) is a potent semi-synthetic hallucinogen derived from ergot alkaloids of rye fungus.
- Usually taken orally as blotter paper (soaked squares), microdots (tablets), or liquid drops.
- Onset occurs within 30โ60 minutes, with effects lasting 6โ12 hours depending on dose, setting, and individual metabolism.
โ๏ธ Pharmacology
- LSD is a serotonergic hallucinogen, acting primarily as a partial agonist at the 5-HT2A receptor in cortical pyramidal neurons.
- It also affects dopaminergic and adrenergic receptors, leading to complex behavioural and autonomic changes.
- Extremely potent: active at 20โ100 ยตg doses; no established lethal dose in humans.
- Metabolised hepatically and excreted mainly as 2-oxy-LSD (inactive).
๐ง Clinical Effects
- Autonomic: Tachycardia, hypertension, mydriasis, dry mouth, sweating, hyperthermia.
- Neurological: Visual distortions, synaesthesia (mixing of senses), altered sense of time and reality, impaired coordination.
- Psychiatric:
- Euphoria, spiritual insight, or heightened awareness.
- โBad tripโ โ panic, agitation, paranoia, fear of death.
- Transient or persistent psychosis in predisposed individuals.
- Long-term risks: Hallucinogen Persisting Perception Disorder (HPPD) (visual flashbacks), anxiety, or depressive relapse.
๐ฌ Investigations
- LSD is rarely detected on standard toxicology screens due to its low dose and rapid metabolism.
- Specialised assays (e.g. GC-MS) can detect urinary 2-oxy-LSD for up to 24 hours.
- Routine work-up focuses on ruling out trauma, metabolic disturbances, or co-intoxication.
โ ๏ธ Complications
- Accidental injury, falls, or self-harm during hallucination or disorientation.
- Persistent psychosis, especially with underlying schizophrenia or bipolar disorder.
- Seizures are rare โ usually associated with co-ingestants (e.g. MDMA, amphetamines).
- Rhabdomyolysis and hyperthermia in severe agitation.
๐ Management
- Initial approach: ABCs, monitor vitals, ensure safety.
- Place in a quiet, low-stimulus environment with calm reassurance โ most resolve with supportive care alone.
- Agitation or panic: Benzodiazepines (e.g. diazepam or lorazepam).
- Persistent psychosis: Short-term antipsychotic (e.g. haloperidol) may be used cautiously.
- Treat any co-ingestant effects (e.g. dehydration, hyperthermia, trauma).
๐งฉ Harm Reduction Notes
- LSD is not physiologically addictive but may cause psychological dependence.
- Avoid use in individuals with underlying psychiatric illness (e.g. schizophrenia, bipolar disorder).
- Potency varies widely among street preparations โ risk of overdose and unpredictable reactions.
- โSet and settingโ (userโs mindset and environment) profoundly influence experience and risk.
๐ References
๐ง Teaching tip:
LSD toxicity is rarely fatal โ the danger lies in behavioural disinhibition and psychosis.
Always prioritise a calm setting, reassurance, and benzodiazepines over restraint. ๐